We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBAN icon
476
Huntington Bancshares
HBAN
$34.4B
$2.29M 0.01%
164,042
+18,652
+13% +$241K
O icon
477
Realty Income
O
$59.6B
$2.29M 0.01%
42,292
+10,035
+31% +$543K
ATO icon
478
Atmos Energy
ATO
$28.8B
$2.29M 0.01%
19,233
+248
+1% +$28.4K
MAS icon
479
Masco
MAS
$14.1B
$2.28M 0.01%
28,847
+23
+0.1% +$1.66K
SEDG icon
480
SolarEdge
SEDG
$2.51B
$2.28M 0.01%
32,052
+9,095
+40% +$656K
MNSO icon
481
MINISO
MNSO
$3.88B
$2.27M 0.01%
110,500
-591,073
-84% -$11.3M
GPN icon
482
Global Payments
GPN
$23B
$2.25M 0.01%
16,820
+935
+6% +$124K
DD icon
483
DuPont de Nemours
DD
$18.5B
$2.24M 0.01%
23,282
-1,832
-7% -$163K
ADM icon
484
Archer Daniels Midland
ADM
$38.2B
$2.21M 0.01%
35,244
+694
+2% +$40.7K
WY icon
485
Weyerhaeuser
WY
$18B
$2.17M 0.01%
60,355
-86,119
-59% -$2.91M
PLTR icon
486
Palantir
PLTR
$295B
$2.15M 0.01%
93,383
+11,257
+14% +$240K
EFX icon
487
Equifax
EFX
$20.3B
$2.15M 0.01%
8,030
+641
+9% +$163K
HDB icon
488
HDFC Bank
HDB
$123B
$2.13M 0.01%
76,002
-41,998
-36% -$1.19M
EQR icon
489
Equity Residential
EQR
$24.9B
$2.13M 0.01%
33,698
-2,436
-7% -$148K
INVH icon
490
Invitation Homes
INVH
$17.7B
$2.11M 0.01%
59,280
+33,871
+133% +$1.15M
FITB
491
Fifth Third Bancorp
FITB
$51.2B
$2.09M 0.01%
56,259
+1,644
+3% +$57.2K
FWONA icon
492
Liberty Media Series A
FWONA
$22.5B
$2.09M 0.01%
35,620
-14,334
-29% -$866K
MNST icon
493
Monster Beverage
MNST
$94.3B
$2.08M 0.01%
35,131
+1,372
+4% +$78.9K
DG icon
494
Dollar General
DG
$28B
$2.06M 0.01%
13,194
+1,841
+16% +$262K
K
495
DELISTED
Kellanova
K
$2.06M 0.01%
35,890
-41
-0.1% -$2.26K
CDW icon
496
CDW
CDW
$18.9B
$2.05M 0.01%
8,015
+96
+1% +$22.8K
WBA
497
DELISTED
Walgreens Boots Alliance
WBA
$2.04M 0.01%
94,281
+12,828
+16% +$285K
VRT icon
498
Vertiv
VRT
$93B
$2.01M 0.01%
24,630
+19,485
+379% +$1.22M
CLX icon
499
Clorox
CLX
$11.6B
$2M 0.01%
13,092
+1,833
+16% +$274K
CHRW icon
500
C.H. Robinson
CHRW
$17.4B
$2M 0.01%
26,284
+5,605
+27% +$438K

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.